Yohimbine in erectile dysfunction: Would an orphan drug ever be properly assessed?

World Journal of Urology

Volumn 19, Issue 4, 2001, Pages 251-255

  Morales, Alvaro ^a,b  

^a KINGSTON GENERAL HOSPITAL   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; YOHIMBINE;

DRUG MANUFACTURE; HUMAN; IMPOTENCE; MALE; REVIEW;

ADRENERGIC ALPHA-ANTAGONISTS; HUMANS; IMPOTENCE; MALE; ORPHAN DRUG PRODUCTION; YOHIMBINE;

EID: 0035431233     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003450000182     Document Type: Article

References (43)

1. Morales A, Condra MS, Owen JE, Surridge DH (1988) Oral and transcutaneous pharmacological agents in the treatment of impotence. Urol Clin North Am 15: 87-93
2. Heaton JPW, Adams MA, Morales A (1997) A therapeutic taxonomy of treatments for erectile dysfunction: an evolutionary imperative. Int J Impôt Res 9: 115-118
3. Christ GJ (1998) A new frontier: gene therapy for erectile dysfunction. In: Morales A (ed) Erectile dysfunction. Issues in current pharmacotherapy. Martin Dunitz, London, pp 209-230
4. Saenz de Tejada I, Kim NN, Traish AM (2000) Regulation of pre-synaptic alphaadrenergic activity in the corpus cavernosum. Int J Impôt Res 12 [Suppl 1]: 20-25
5. Tarn SW, Letts LG, Worcel M, Wyllie M (2001) Yohimbine: a clinical review, (submitted)
6. Morales A (2000) Yohimbine in erectile dysfunction: the facts. Int J Impôt Res 12 [Suppl 1]: 70-74
7. Rodriguez-Manso G, Fernandez-Guati A (1994) Reversal of sexual exhaustion by serotonergic and noradrenergic agents. Behav Brain Res 62: 127-134
8. Giuliano F, Rampin O (2000) Central noradrenergic control of penile erection. Int J Impôt Res 12 [Suppl 1] 13-19
9. Bancroft J (2000) Effects of alpha-2 blockade on sexual response: experimental studies with delequamine. Int J Impôt Res 12 [Suppl 1] 64-69
10. Goldstein 1 (2000) Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction. Int J Impôt Res 12 [Suppl 1] 75
11. Traish A, Kim NN. Moreland RB, Goldstein I (2000) Role of alpha adrenergic receptors in erectile function. Int J Impôt Res 12 [Suppl 1]: 48-63
12. Murburg MM, Villacres EC, Ko GN, Veith RC (1991) Effects of yohimbine on human sympathetic nervous system function. J Clin Endocrinol Metab 73: 861-865
13. Traish A, Kim NK, Goldstein I (2000) Role of alpha adrenergic receptors in erectile function. Int J Impôt Res 12 [Suppl 1]: 48-63
14. Feuerstein TJ, Hertting G, Jackish R (1985) Endogenous adrenaline as modulator of hipoccampal serotonin release. Dual effect of yohimbine, rauwolscine and corynanthine as y.adrenoceptor antagonists and 5-HT-receptor agonists. Naunyn Schmidebergs Arch Pharmacol 329: 216-221
15. Nickerson M, Collier B (1975) Drugs inhibiting adrenergic nerves and structures innervated by them. In: Goodman L, Oilman A (eds) The pharmacological basis of therapeutics. McMillan, New York 75: 533-564
16. Margolis A, Prieto P, Stein L (1971) Statistical summary of 10,000 male cases using Afrodex in the treatment of impotence. Curr Ther Res 13: 616-620
17. Wolpowitz C, Barnard CN (1978) Impotence in heart transplantation. S Afr Med J 53: 693
18. Margolis R, Leslie CH (1969) Review of studies on a mixture of nux vomica, yohimbine and testosterone in the management of male impotency: a double blind crossover study. Curr Ther Res 11: 87-92
19. Morales A, Surridge DA, Marshall PG, Fenemore J (1982) Non-hormonal pharmacological treatment of organic impotence. J Urol 128: 45
20. Morales A, Condra M, Owen JA, Surridge DH, Fenemore J (1987) Is yohimbine effective in the treatment of organic impotence?; Urol 137: 1168-1171
21. Reid K, Surridge DH, Morales A, Fenemore J (1987) Double blind trial of yohimbine in the treatment of psychogenic impotence. Lancet 2: 421
22. Anonymous(1981) Medicine: More than a reputation. Time Magazine, December 14
23. Jacobsen FM (1992) Fluoxetine sexual dysfunction and an open trial of yohimbine. J Clin Psychiatry 53: 119-122
24. Hollander E. McCarley A (1992) Yohimbine treatment of sexual side effects by serotonin reuptake blockers. J Clin Psychiatry 53: 207-209
25. Vickers MA, de Nobrega AM, Dluhy RG (1993) Diagnosis and treatment of psychogenic erectile dysfunction in a urological setting. J Urol 149: 1258
26. Riley AJ, Goodman R, Kellett JM, Orr R (1989) Double blind trial of yohimbine hydrochloride in the treatment of erectile inadequacy. Sex Marital Ther 4: 17-22
27. Susset JG, Tessier CD, Wincze J. Banzai S, Malhotra C, Schwacha MG (1989) Effect of yohimbine hydrochloride on erectile impotence. J Urol 141: 1360
28. Mann K, Klinger T, Noe S, Rock J, Muller S, Banker O ( 1996) Effects of yohimbine on sexual experiences and nocturnal penile tumescence and rigidity in erectile dysfunction. Arch Sex Behav 25: 1-5
29. Volt HJ, Brand P, Kocoktt G, Scmitz JR, Wegand MH, Schadrak J, Gierend M (1997) Double-blind, placebo controlled safety and efficacy trial with yohimbine hydrochloride in the treatment of non-organic erectile dysfunction. Int J Impôt Res 9: 155-161
30. Rowland DL, Kalian K, Slob K (1997) Yohimbine, erectile dysfunction and sexual response in man. Arch Sex Behav 26: 49-53
31. Teloken C. Rhoden EL, Sogari P. Dambros M, Souto CAV (1998) Therapeutic effects of high dose yohimbine hydrochloride an organic erectile dysfunction J Urol 158: 122-124
32. Kunelius P. Hakkinen J, Lukkarinen O (1997) Is high dose yohimbine hydrochloride effective in the treatment of mixed type impotence? A prospective, randomized, controlled double blind, crossover study. Urology 49: 441-4444
33. Traish A, Kim NN, Huang YH, Goldstein I, Moreland RB (2000) Cyclic AMP regulated mRNA expression of alpha-Id and alpha-2a adrenergic receptors in cultured human corpus cavernosum smooth muscle cells. Int J Impôt Res 12 [Suppl 1]: 41-47
34. Carey MP, Johnson BT (1996) Effectiveness of yohimbine in the treatment of erectile disorder: four meta-analytic integrations. Arch Sex Behav 4: 341
35. Ernst E, Pittler MH (1998) Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol 159:433-436
36. The American Urological Association Erectile Dysfunction Clinical Guidelines Panel (1996) The Treatment of Organic Erectile Dysfunction
37. Traish AM, Moreland RB, Huang YH, Goldstein I (1997) Expression of functional x2-adrenergic receptor subtypes in human corpus cavernosum and in cultured trabecular smooth muscle cells. Recept Human Transduct 7: 55-67
38. Clark JT, Smith ER, Davidson JM (1984) Enhancement of sexual motivation in male rats by yohimbine. Science 225: 847-849
39. Clark JT, Smith ER, Davidson JM (1985) Evidence for the modulation of sexual behavior by alpha-adrenoceptors in male rats. Neuroendocrinology 41-443
40. Owen JA, Nakatsu SL, Condra M, Surridge DM, Morales A (1985) Subnanogram analysis of yohimbine and related compounds by high-performance liquid chromatography. J Chromatogr 342: 333-340
41. Lawrence KM, Barfield RJ (1975) Differential rates of exhaustion and recovery of several parameters of male rat sexual behavior. J Comp Physiol Psychol 88: 693-703
42. Rodriguez-Manzo G, Fernandez-Guasti A (1995) Participation of the central noradrenergic system in the re-establishment of the copulatory behavior of sexually exhausted rats by yohimbine. naloxone and 8-OH-DPAT. Brain Res Bull 39: 394-404
43. Sachs BD, Meisel RL (1988) The physiology of male sexual behavior. In: Knobil E, Neill JD (eds) The physiology of reproduction, vol II. Raven, New York, pp 1393-1485